Industry reports
Editor highlights

Atorvastatin Research Reports, April 2014

You might be interested in: therapeutics, angina, angina pectoris, more »


 

1-10 of 18 reports for Atorvastatin
Kopran Limited (KOPRAN) - Financial and Strategic SWOT Analysis Review

Kopran Limited (KOPRAN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... Of parijat enterprises. The company product includes albendazole, tinidazole, levoceterizine, fluconazole, paracetamol, atorvastatin, losartan potassium, glibenclamide, famotidine, and rabeprazole, among ...

Atorvastatin  - Comprehensive patent search

Atorvastatin - Comprehensive patent search

  • $ 6 400
  • Company report
  • March 2014
  • by GenericsWeb

... But delivers categorisation and interpretation, all delivered by a convenient online interface. The pipeline developer report covers atorvastatinatorvastatin indications: inhibition of cholesterol ...

Atorvastatin - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

Atorvastatin - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

  • $ 1 105
  • Industry report
  • March 2014
  • by GenericsWeb

... atorvastatin - key patent, spc, and data exclusivity expiry (44 countries coverage) pipeline selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate ...

Atorvastatin - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Atorvastatin - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • March 2014
  • by GenericsWeb

... atorvastatin - key patent, spc, and data exclusivity expiry (7 country coverage) pipeline selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot ...

Atorvastatin - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

Atorvastatin - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

  • $ 1 200
  • Company report
  • March 2014
  • by Generics Web - Selector 44

... Selector report covers atorvastatinatorvastatin indications: inhibition of cholesterol biosynthesis; treatment of hyperlipidemia and hypercholesterolemiaatorvastatin innovator: pfizer (lipitor ...

Atorvastatin - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

Atorvastatin - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

  • $ 500
  • Company report
  • March 2014
  • by GenericsWeb - Selector 7

... Selector report covers atorvastatinatorvastatin indications: inhibition of cholesterol biosynthesis; treatment of hyperlipidemia and hypercholesterolemiaatorvastatin innovator: pfizer (lipitor ...

Kopran Limited (KOPRAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kopran Limited (KOPRAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Company of parijat enterprises. The company product includes albendazole, tinidazole, levoceterizine, fluconazole, paracetamol, atorvastatin, losartan potassium, glibenclamide, famotidine, and rabeprazole ...

Indoco Remedies Limited (INDOCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Indoco Remedies Limited (INDOCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Hydrochloride, betaxolol hydrochloride, brimonidine tartrate, bromfenac sodium, atorvastatin calcium, brinzolamide, rasagiline mesylate, pregabalin, and olopatadine hydrochloride. It offers products in the fields ...

Arch Pharmalabs Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Arch Pharmalabs Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... And supplies various generic apis and pharmaceutical intermediates for pharmaceutical players in both domestic and international markets. Its products include atorvastatin calcium, atorvastatin calcium ...

Sarcoidosis - Pipeline Review, H2 2013

Sarcoidosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

... Rituximab - drug profile 41product description 41mechanism of action 41r&d progress 41atorvastatin calcium - drug profile 42product description 42mechanism of action 42r&d progress 42 ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.